Sachem Head Capital Management LP Adma Biologics, Inc. Transaction History
Sachem Head Capital Management LP
- $2.33 Billion
- Q3 2025
A detailed history of Sachem Head Capital Management LP transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Sachem Head Capital Management LP holds 8,960,000 shares of ADMA stock, worth $139 Million. This represents 5.63% of its overall portfolio holdings.
Number of Shares
8,960,000Holding current value
$139 Million% of portfolio
5.63%Shares
1 transactions
Others Institutions Holding ADMA
# of Institutions
398Shares Held
193MCall Options Held
2.36MPut Options Held
1.93M-
Vanguard Group Inc Valley Forge, PA21MShares$326 Million0.0% of portfolio
-
Black Rock Inc. New York, NY18.6MShares$290 Million0.0% of portfolio
-
State Street Corp Boston, MA13.6MShares$211 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.5MShares$195 Million0.03% of portfolio
-
Geode Capital Management, LLC Boston, MA5.81MShares$90.5 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.06B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...